Share
(SAN DIEGO, Cal.) – A new cancer research partnership in New Brunswick will generate real-world evidence on the epidemiology and management of large B-Cell lymphoma (LBCL), providing a comprehensive understanding of lymphoma management practices and their impact on patient care.
Researchers at New Brunswick Institute for Research, Data and Training (NB-IRDT) and Horizon Health Network will collaborate with AbbVie’s Canadian affiliate to describe disease statistics, patient characteristics, treatment pathways and associated healthcare resource utilization across New Brunswick’s entire population over a 15-year period.
“Using linked patient-level data drawn from multiple data systems on patients from across New Brunswick, this study will give decisionmakers a better understanding of LBCL’s impact on patients and the healthcare system by studying drug efficacy outside of randomized control trial settings,” said Ted McDonald, director of NB-IRDT.
The partnership will draw on linked administrative data from the New Brunswick Cancer Registry, the province’s cancer treatment centres, and other health and demographic databases. The data are held at NB-IRDT at the University of New Brunswick, which is home to one of the most complete sets of linkable person-level data in Canada.
“People living with large B-cell lymphoma face an aggressive disease that can rapidly progress and resist treatment, which can have a significant impact on patients. We are proud to partner with the NB-IRDT and Horizon Health Network to better understand the real-world gaps in LBCL patient care,” said Rami Fayed, Vice President and General Manager, AbbVie in Canada. “This important partnership will generate meaningful data that will help advance standards of care and ultimately make a remarkable impact in people’s lives.”
The partners finalized arrangements for this new project with the support of ResearchNB at the BIO international Convention in San Diego.
“New Brunswick has world-class capabilities in real-world evidence, and we are thrilled that AbbVie and NB-IRDT are working together again,” said Damon Goodwin, chief executive officer of ResearchNB. “The administrative data resources hosted by NB-IRDT are an incredible resource for researchers seeking to understand the prevalence and treatment of any disease.”
About NB-IRDT
Located at the University of New Brunswick, the New Brunswick Institute for Research, Data and Training (NB-IRDT) is the province’s official data repository. NB-IRDT manages a growing collection of administrative data resources supplied primarily by the provincial government, including demographic, socioeconomic, health, and education data. The data are pseudonymized to protect privacy and linkable at the individual level to meet diverse research needs. For more information about the NB-IRDT, please visit us at https://www.unb.ca/nbirdt/. Follow the NB-IRDT on Twitter, on Instagram or find us on LinkedIn.
About ResearchNB
ResearchNB is the province’s research and innovation enabler. With offices in Fredericton, Saint John and Moncton, it provides New Brunswick’s research sector with critical leadership and support including advocacy, initial funding, connections to potential partners, and the translation of science into economic opportunities. Projects developed in partnership with ResearchNB help New Brunswickers to thrive through research that leads to new, innovative business practices and products.
About AbbVie
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.ca. Follow AbbVie Canada on Twitter, on Instagram or find us on LinkedIn.
-30-
For more information:
Patti Ryan
ResearchNB
506-455-8886
patti@researchnb.ca
Julie Lepsetz
AbbVie Corporation
514-451-9427
Julie.lepsetz@abbvie.com
Kathleen McLaughlin
Media Relations Strategist
University of New Brunswick
506-261-7788
Talktous@unb.ca
